Please assess the completion status of the following clinical trial:

Trial Title: Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age or older~* HIV-positive~* Initiated ARV's containing tenofovir 4 or more months ago~* Speaks English or Xhosa~* Willing to attend 5 study visits approximately one month apart~* Willing to allow the study team to contact his/her HIV care provider about his/her monthly TFV-diphosphate (TFV-DP) drug level~* Willing to use Wise Pill to dispense ARVs for 4 months~* Willing to receive text/short message service (SMS) and/or phone call reminders to charge the Wise Pill~* Willing to allow the study team access to their medical chart/clinic folder~Exclusion Criteria:~* Unable to provide informed consent~* Unwilling to participate in study procedures~* Unwilling to allow the study team to contact his/her HIV care provider about his/her monthly TFV-DP drug level~* Any condition that, in the opinion of the principal investigator would make participation in the study unsafe, complicated interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Receiving Feedback From DBS (Type: EXPERIMENTAL): This arm of participants will receive monthly feedback from medical providers on their adherence measured through DBS.

Based on this trial design, predict the completion outcome and termination type (if applicable).